Semantic Scholar uses AI to extract papers important to this topic.
Pembrolizumab is a humanized monoclonal antibody against programmed death 1 (PD-1) that has antitumor activity in… Expand Follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are the two most common non-Hodgkin lymphomas (NHLs). Here we… Expand Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically heterogeneous: 40% of… Expand Standardized guidelines for response assessment are needed to ensure comparability among clinical trials in non-Hodgkin's… Expand Increasing knowledge about the biology of the non-Hodgkin's lymphomas has led to new approaches in classification. Rather than… Expand The recognition of several new types of non-Hodgkin's lymphoma (NHL) in recent years has led to proposals for changing lymphoma… Expand BACKGROUND
High-dose chemotherapy followed by autologous bone marrow transplantation is a therapeutic option for patients with… Expand The 2;5 chromosomal translocation occurs in most anaplastic large-cell non-Hodgkin's lymphomas arising from activated T… Expand BACKGROUND
Although many patients with intermediate-grade or high-grade (aggressive) non-Hodgkin's lymphoma are cured by… Expand BACKGROUND
CHOP is a first-generation, combination-chemotherapy regimen consisting of cyclophosphamide, doxorubicin, vincristine… Expand